Lawyers React To High Court's Generic-Drug Liability Ruling
The U.S. Supreme Court ruled 5-4 Monday that users of generic drugs cannot bring state-law design defect claims against generics makers because the manufacturers cannot change a drug's design under federal...To view the full article, register now.
Already a subscriber? Click here to view full article